Dudediligence.

Aldeyra Therapeutics, Inc

ALDXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$15.1MSep ’24−$15.8MDec ’24−$9.9MMar ’25−$9.8MJun ’25−$7.7MSep ’25−$6.5MDec ’25−$3.5MMar ’26−$5.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$56.2M−$62.7M−$42.8M−$60.1M−$35.3M
Net income−$57.8M−$62.0M−$37.5M−$55.9M−$33.8M
Operating cash flow−$42.6M−$56.6M−$30.3M−$43.2M−$33.3M
Free cash flow−$42.6M−$56.7M−$30.3Mnone on filenone on file
Cash$229.8M$144.4M$142.8M$54.5M$70.0M
Debt$15.5M$15.8M$15.1M$15.0M$15.2M
Shares outstanding58.1M58.6M59.2M59.6M60.2M